Table 4.
ALL, acute lymphoblastic leukemia; AML, acute myeloid leukemia; CML, chronic myeloid leukemia; FEV1, forced expiratory volume in 1s; FVC, forced vital capacity; NA, not available; IST, immunosuppressive treatment; GvHD, graft-versus-host disease.
*Mean follow-up duration since diagnosis of lung GvHD: 23.0 months (range: 6.2-36.3).